Dr. Doyle received his medical degree from the University of Maryland School of Medicine, where he completed internship and residency training in Internal Medicine. Dr. Doyle completed a medical oncology fellowship in the NCI-Navy Medical Oncology Branch of NCI. He joined the faculty of the Greenebaum Cancer Center, at the University of Maryland School of Medicine, and rose to the rank of Professor of Medicine and Oncology. Dr. Doyle's significant laboratory work involved membrane transporters involved in cancer multidrug resistance, and his clinical work was in thoracic and gastrointestinal malignancies. Since joining the Investigational Drug Branch of CTEP, Dr. Doyle has developed a portfolio of agents including signal transduction inhibitors, mitosis-directed therapeutics, cell cycle-regulatory agents, and drugs involved with DNA damage response.
National Cancer Institute
Executive Plaza North, Suite 7122
Rockville MD, 20852-7426